
Artificial intelligence-based volumetric measurements for longitudinal clinical assessment of treatment response in high-grade gliomas: Validation across institutional and public datasets.
AI in High-Grade Glioma Treatment: 1648 MRI Sequences Analyzed, 15s Segmentation Time, Moderate Agreement with MDTB Diagnoses 📊🧠







